Jaguar Health (JAGX) Gross Margin (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Gross Margin of 94.29% for Q1 2026, up 1755.0% year-over-year from 5.08% in Q1 2025, and up 194.71% quarter-over-quarter from 31.99% in Q4 2025.
Jaguar Health (JAGX) Gross Margin (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Gross Margin for 12 consecutive years, with 94.29% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin rose 1755.0% year-over-year to 94.29%; the TTM figure through Mar 2026 stood at 85.06% (up 272.0% YoY), while the FY2025 annual figure was 67.21%, down 1606.0% from the prior year.
- Gross Margin rose to 94.29% in Q1 2026 per JAGX's latest filing, from 31.99% in the prior quarter.
- Across five years, Gross Margin topped out at 94.29% in Q1 2026 and bottomed at 2175.0% in Q1 2022.
- Historically, Gross Margin has averaged 187.63% across 5 years, with a median of 81.71% in 2024.
- Annual changes were most pronounced in 2022 — Gross Margin tumbled 222674 bps — and 2023, when it surged 151701 bps.
- Jaguar Health's Gross Margin stood at 1446.88% in 2022, then jumped by 105 bps to 70.13% in 2023, then grew by 20 bps to 84.13% in 2024, then plunged by 62 bps to 31.99% in 2025, then jumped by 195 bps to 94.29% in 2026.
- Business Quant data shows JAGX's Gross Margin at 94.29% in Q1 2026, 31.99% in Q4 2025, and 82.74% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 94.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.29% |
| Dec 31, 2025 | 31.99% |
| Sep 30, 2025 | 82.74% |
| Jun 30, 2025 | 82.31% |
| Mar 31, 2025 | 76.74% |
| Dec 31, 2024 | 84.13% |
| Sep 30, 2024 | 82.59% |
| Jun 30, 2024 | 84.31% |
| Mar 31, 2024 | 81.71% |
| Dec 31, 2023 | 70.13% |
| Sep 30, 2023 | 81.73% |
| Jun 30, 2023 | 81.31% |
| Mar 31, 2023 | -666.67% |
| Dec 31, 2022 | -1,446.88% |
| Sep 30, 2022 | 80.43% |
| Jun 30, 2022 | 84.39% |
| Mar 31, 2022 | -2,175.00% |
| Dec 31, 2021 | 77.45% |
| Sep 30, 2021 | -0.33% |
| Jun 30, 2021 | -75.20% |